545 related articles for article (PubMed ID: 27011261)
21. Effect of dietary saturated fatty acids on HNF-4α DNA binding activity and ApoCIII mRNA in sedentary rat liver.
Ceccarelli V; Nocentini G; Riccardi C; Ayroldi E; Di Nardo P; Roberti R; Binaglia L; Vecchini A
Mol Cell Biochem; 2011 Jan; 347(1-2):29-39. PubMed ID: 20938723
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease.
Li T; Huang X; Yue Z; Meng L; Hu Y
Cell Biochem Funct; 2020 Oct; 38(7):839-846. PubMed ID: 32212193
[TBL] [Abstract][Full Text] [Related]
23. Involvement of AMPK activation in the inhibition of hepatic gluconeogenesis by Ficus carica leaf extract in diabetic mice and HepG2 cells.
Zhang Y; Chen J; Zeng Y; Huang D; Xu Q
Biomed Pharmacother; 2019 Jan; 109():188-194. PubMed ID: 30396076
[TBL] [Abstract][Full Text] [Related]
24. PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.
Xia N; Tang Z; Wang C; Xu G; Nie X; Zhang W; Zhao Y; Wang S; Zhu X; Cui S
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):116-22. PubMed ID: 26002461
[TBL] [Abstract][Full Text] [Related]
25. Suppression of VLDL secretion by cultured hepatocytes incubated with chylomicron remnants enriched in n-3 polyunsaturated fatty acids is regulated by hepatic nuclear factor-4alpha.
López-Soldado I; Avella M; Botham KM
Biochim Biophys Acta; 2009 Dec; 1791(12):1181-9. PubMed ID: 19699314
[TBL] [Abstract][Full Text] [Related]
26. Hepatocyte nuclear factor-4alpha contributes to carbohydrate-induced transcriptional activation of hepatic fatty acid synthase.
Adamson AW; Suchankova G; Rufo C; Nakamura MT; Teran-Garcia M; Clarke SD; Gettys TW
Biochem J; 2006 Oct; 399(2):285-95. PubMed ID: 16800817
[TBL] [Abstract][Full Text] [Related]
27. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha.
Selva DM; Hammond GL
J Mol Endocrinol; 2009 Jul; 43(1):19-27. PubMed ID: 19336534
[TBL] [Abstract][Full Text] [Related]
28. The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity.
Yarushkin AA; Kachaylo EM; Pustylnyak VO
Br J Pharmacol; 2013 Apr; 168(8):1923-32. PubMed ID: 23231652
[TBL] [Abstract][Full Text] [Related]
29. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
30. Thyroid-Stimulating Hormone Increases HNF-4α Phosphorylation via cAMP/PKA Pathway in the Liver.
Song Y; Zheng D; Zhao M; Qin Y; Wang T; Xing W; Gao L; Zhao J
Sci Rep; 2015 Aug; 5():13409. PubMed ID: 26302721
[TBL] [Abstract][Full Text] [Related]
31. knocking down liver ccaat/enhancer-binding protein alpha by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db/db mice.
Qiao L; MacLean PS; You H; Schaack J; Shao J
Endocrinology; 2006 Jun; 147(6):3060-9. PubMed ID: 16543372
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats.
Song D; Yin L; Wang C; Wen X
PLoS One; 2019; 14(6):e0210930. PubMed ID: 31233505
[TBL] [Abstract][Full Text] [Related]
33. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
[TBL] [Abstract][Full Text] [Related]
34. The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal Farnesoid X Receptor Signaling Pathway and Inhibition of Hepatic Gluconeogenesis.
Sun R; Kong B; Yang N; Cao B; Feng D; Yu X; Ge C; Feng S; Fei F; Huang J; Lu Z; Xie Y; Yang CS; Guo GL; Wang G; Aa J
Drug Metab Dispos; 2021 Mar; 49(3):276-286. PubMed ID: 33376148
[TBL] [Abstract][Full Text] [Related]
35. cAMP-mediated regulation of HNF-4alpha depends on the level of coactivator PGC-1alpha.
Dankel SN; Hoang T; Flågeng MH; Sagen JV; Mellgren G
Biochim Biophys Acta; 2010 Sep; 1803(9):1013-9. PubMed ID: 20670916
[TBL] [Abstract][Full Text] [Related]
36. Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
Dong Y; Gao G; Fan H; Li S; Li X; Liu W
PLoS One; 2015; 10(4):e0124778. PubMed ID: 25909991
[TBL] [Abstract][Full Text] [Related]
37. Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA
Li J; Du H; Zhang M; Zhang Z; Teng F; Zhao Y; Zhang W; Yu Y; Feng L; Cui X; Zhang M; Lu T; Guan F; Chen L
Int J Biol Sci; 2019; 15(7):1533-1545. PubMed ID: 31337982
[No Abstract] [Full Text] [Related]
38. Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation.
Ong KW; Hsu A; Tan BK
Biochem Pharmacol; 2013 May; 85(9):1341-51. PubMed ID: 23416115
[TBL] [Abstract][Full Text] [Related]
39. Activated sterol regulatory element-binding protein-2 suppresses hepatocyte nuclear factor-4-mediated Cyp3a11 expression in mouse liver.
Inoue S; Yoshinari K; Sugawara M; Yamazoe Y
Mol Pharmacol; 2011 Jan; 79(1):148-56. PubMed ID: 20926756
[TBL] [Abstract][Full Text] [Related]
40. Interaction of ApoA-IV with NR4A1 and NR1D1 Represses G6Pase and PEPCK Transcription: Nuclear Receptor-Mediated Downregulation of Hepatic Gluconeogenesis in Mice and a Human Hepatocyte Cell Line.
Li X; Xu M; Wang F; Ji Y; DavidsoN WS; Li Z; Tso P
PLoS One; 2015; 10(11):e0142098. PubMed ID: 26556724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
